NCT05213013

Brief Summary

The aim of this study is to determine the effect of toy-type nebulizers on fear and anxiety in children receiving inhaler therapy. The research hypotheses are as follows: H0: There is no significant difference between the intervention group and the the control group in the mean score of the "Child Fear Scale" and "Child Anxiety Scale-State" during and after the inhaler treatment with a toy-type nebulizer. H1: During and after the s inhaler treatment with the toy-type nebulizer, the mean score of the "Child Fear Scale" and "Child Anxiety Scale-State" is significantly higher in the intervention group compared to the control group.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 4, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 28, 2022

Completed
2 days until next milestone

Study Start

First participant enrolled

January 30, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 28, 2023

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2023

Completed
Last Updated

February 8, 2023

Status Verified

February 1, 2023

Enrollment Period

12 months

First QC Date

December 4, 2021

Last Update Submit

February 6, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Difference between the mean score of the "Child Fear Scale" between intervention and control groups

    "The Child Fear Scale" will be completed before training and inhaler treatment with toy-type treatment that gathers quantitative data that will fear about the inhaler treatment with a nebulizer in children. This scale will also be completed at the intervention during and ten minutes after the intervention. The quantitative data will be used to measure a change in the children's fear level before, during and after the proposed intervention. The scale will be made without training and inhaler treatment with a standard nebulizer in the control group. At the end of the study, difference between the mean score of "The Child Fear Scale" between intervention and control groups will be examined. The Child Fear Scale total score mean of the children in the intervention group will be higher after the intervention compared to the control group. Data will be analyzed using Statistical Package for the Social Sciences package program.

    12 months

  • Difference between the mean score of "The Child Anxiety Meter-State" between intervention and control groups

    "The Child Anxiety Meter-State" will be completed before training and inhaler treatment with toy-type treatment that gathers quantitative data that will anxiety about the inhaler treatment with a nebulizer in children. This scale will also be completed at the intervention during and ten minutes after the intervention. The quantitative data will be used to measure a change in the children's anxiety level before, during and after the proposed intervention. The scale will be made without training and inhaler treatment with a standard nebulizer in the control group. At the end of the study, difference between the mean score of "The Child Anxiety Meter-State" between intervention and control groups will be examined. The Child Anxiety Meter-State total score mean of the children in the intervention group will be higher after the intervention compared to the control group. Data will be analyzed using Statistical Package for the Social Sciences package program.

    12 months

Secondary Outcomes (2)

  • Change of the mean scores obtained by the children in the intervention group from the "Child Fear Scale" before and after the intervention.

    12 months

  • Change of the mean scores obtained by the children in the intervention group from the "Child Anxiety Meter-State" before and after the intervention.

    12 months

Study Arms (2)

Experimental

EXPERIMENTAL

All registered participants in the control group, will receive inhaler treatment with the toy-type nebulizer in the hospital. Both the parent and the child in the intervention group will be trained on the use of a nebulizer/mask.

Other: inhaler treatment with the toy-type nebulizer and training on on the use of a nebulizer/mask

No intervention

NO INTERVENTION

No intervention. All registered participants in the control group, will receive inhaler treatment with the standard nebulizer in the hospital. Both the parent and the child in the intervention group will not be trained on the use of a nebulizer/mask.

Interventions

The children (experimental group), will receive training and inhaler treatment with the toy-type nebulizer. The training topics is as follows: * For effective nebulization, it should be ensured that the parts of the mask are assembled completely and correctly. * The child should be in an upright sitting position during nebulization. * During the procedure, normal breathing should be given into the mask. * As the medicine is finished, a sizzling sound is heard from the device. * After the nebula is over, the face should be washed and the mouth should be rinsed to remove the drug residues accumulated on the face and mouth.

Experimental

Eligibility Criteria

Age4 Years - 10 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • The child is between the ages of 4-10
  • The child's application to the Pediatric Emergency Unit
  • Child receiving inhaler treatment for the first time
  • Parent and child agreeing to participate in the project
  • Absence of speech and visual impairment of the child and his parents

You may not qualify if:

  • The child is not between the ages of 4-10
  • The child's application to another department except for the Pediatric Emergency Unit
  • Child not receiving inhaler treatment for the first time
  • Parent and child not agreeing to participate in the project
  • Having speech and visual impairment of the child and his parents

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bartın University

Bartın, 74100, Turkey (Türkiye)

RECRUITING

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
Children and their parents
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Children and their parents
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 4, 2021

First Posted

January 28, 2022

Study Start

January 30, 2022

Primary Completion

January 28, 2023

Study Completion

January 30, 2023

Last Updated

February 8, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL
Time Frame
12 months

Locations